ProFrac Sells 18.75M Shares; Underwriters Have 30-Day Option
Rhea-AI Filing Summary
On August 12, 2025, ProFrac Holding Corp. entered an underwriting agreement with J.P. Morgan Securities LLC and Piper Sandler & Co. for an offering of 18,750,000 shares of Class A common stock, and granted the underwriters a 30-day option to purchase up to an additional 2,812,500 shares. The sale of the Firm Shares closed on August 14, 2025, producing approximately $72.8 million in net proceeds to the company after underwriting fees and commissions and before expenses. The offering was registered on Form S-3 (Registration No. 333-273453) with a prospectus supplement dated August 12, 2025. The underwriting agreement includes customary representations, warranties and indemnification provisions, and a legal opinion is filed as Exhibit 5.1.
Positive
- Raised approximately $72.8 million in net proceeds from the sale of 18,750,000 Class A shares
- Underwriters granted a 30-day option to purchase up to 2,812,500 additional shares
- Offering registered on Form S-3 (Registration No. 333-273453) with a prospectus supplement dated August 12, 2025
- Sale closed on August 14, 2025, confirming completion of the transaction
- Legal opinion filed as Exhibit 5.1 and underwriting agreement filed as Exhibit 1.1
Negative
- None.
Insights
TL;DR: ProFrac completed an 18.75M-share offering, raising about $72.8M; underwriters hold a 30-day option for 2.8125M additional shares.
The filing documents a completed capital raise under an underwriting agreement with J.P. Morgan and Piper Sandler. Key figures are explicit: 18,750,000 Firm Shares sold and approximately $72.8 million in net proceeds after underwriting fees and commissions, with a 30-day option for up to 2,812,500 additional shares. The offering was registered on a previously effective Form S-3, and closing occurred on August 14, 2025. The agreement contains customary covenants and indemnities, and the underwriters disclosed prior and potential future commercial and investment banking engagements with the company.
TL;DR: Transaction provides stated proceeds and flexibility via an overallotment option; documentation and legal opinion are filed as exhibits.
The 8-K reports a material definitive agreement effectuating a marketed equity sale and immediate closing. The disclosed net proceeds figure (~$72.8 million) is after underwriting fees and commissions and before expenses, and a 30-day option allows underwriters to purchase up to 2,812,500 additional shares. The registration provenance (Form S-3, Reg. No. 333-273453) and the filing of a legal opinion (Exhibit 5.1) are explicitly noted. The agreement’s representations, warranties and indemnities are described as customary, and potential ongoing commercial relationships between the underwriters and the company are disclosed.
FAQ
What did ProFrac (ACDC) do in this 8-K?
How much did ProFrac (ACDC) raise from the offering?
Is there an option for more shares in the ProFrac offering?
Who were the underwriters for ProFrac (ACDC)?
Was the offering registered?
Are there any disclosed conflicts or related-party transactions with the underwriters?